Видео ютуба по тегу Medicines: Cobimetinib

Vemurafenib and cobimetinib in patients with BRAF-mutated melanoma
Vemurafenib and cobimetinib in patients with BRAF-mutated melanoma
Cobimetinib-based treatment for R/R multiple myeloma
Cobimetinib-based treatment for R/R multiple myeloma
Dr. Brufsky on Cobimetinib Plus Paclitaxel in TNBC
Dr. Brufsky on Cobimetinib Plus Paclitaxel in TNBC
Cobimetinib and Atezolizumab in Colorectal Cancer
Cobimetinib and Atezolizumab in Colorectal Cancer
Cobimetinib Plus Paclitaxel in TNBC
Cobimetinib Plus Paclitaxel in TNBC
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutat...
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutat...
Regulatory Approvals for Vemurafenib/Cobimetinib, Necitumumab, and Elotuzumab
Regulatory Approvals for Vemurafenib/Cobimetinib, Necitumumab, and Elotuzumab
Cotellic (cobimetinib)- metastatic melanoma
Cotellic (cobimetinib)- metastatic melanoma
Hamid: Cobimetinib, Zelboraf for Previously Untreated Melanoma
Hamid: Cobimetinib, Zelboraf for Previously Untreated Melanoma
Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
Dr. Weber on Dabrafenib/Trametinib Versus Vemurafenib/Cobimetinib in Melanoma
Dr. Weber on Dabrafenib/Trametinib Versus Vemurafenib/Cobimetinib in Melanoma
Cobimetinib and Atezolizumab vs Pembrolizumab for Advanced Melanoma
Cobimetinib and Atezolizumab vs Pembrolizumab for Advanced Melanoma
Vemurafenib plus cobimetinib achieves significant progression-free survival in melanoma
Vemurafenib plus cobimetinib achieves significant progression-free survival in melanoma
Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...Sullivan
Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...Sullivan